Ebola may soon be a “preventable and treatable” disease after a trial of two drugs showed significantly improved survival rates, scientists have said.
Four drugs were trialed on patients in the Democratic Republic of Congo, where there is a major outbreak of the virus.
More than 90 percent of infected people can survive if treated early with the most effective drugs, the research showed BBC said.
The drugs will now be used to treat all patients with the disease in DR Congo, according to health officials.
On Tuesday, two people cured of Ebola using the experimental drugs were released from a treatment center in Goma, eastern DR Congo, and reunited with their families.
The US National Institute of Allergy and Infectious Diseases (NIAID), which co-sponsored the trial, said the results are “very good news” for the fight against Ebola.
The drugs, named REGN-EB3 and mAb114, work by attacking the Ebola virus with antibodies, neutralising its impact on human cells.
